Trial Profile
Phase I, open, multicenter study, with subcutaneous immunotherapy in depot presentation, in patients with rhinoconjunctivitis sensitized to Olea europaea. [Ensayo clínico fase I, abierto, multicéntrico, con inmunoterapia subcutánea en presentación depot, en pacientes con rinoconjuntivitis sensibilizados a Olea europaea]
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jul 2018
Price :
$35
*
At a glance
- Drugs Allergy immunotherapy (Primary)
- Indications Allergic rhinoconjunctivitis
- Focus Pharmacodynamics
- Sponsors Bial
- 22 Jul 2018 Planned number of patients changed from 52 to 49.
- 09 Jun 2017 Status changed from recruiting to completed.
- 22 Jul 2015 New trial record